HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuo Hamamoto Selected Research

Induction Chemotherapy

2/2021A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
2/2020A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
2/2018Concordance of clinical diagnosis of T classification among physicians for locally advanced unresectable thoracic esophageal cancer.
11/2016Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuo Hamamoto Research Topics

Disease

33Neoplasms (Cancer)
08/2023 - 09/2000
23Stomach Neoplasms (Stomach Cancer)
10/2023 - 09/2000
18Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 05/2005
14Neoplasm Metastasis (Metastasis)
11/2023 - 09/2000
12Esophageal Squamous Cell Carcinoma
03/2023 - 11/2013
12Disease Progression
01/2021 - 09/2000
10Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 06/2011
6Neutropenia
02/2021 - 10/2013
6Pancreatic Neoplasms (Pancreatic Cancer)
10/2018 - 06/2010
5Renal Cell Carcinoma (Grawitz Tumor)
08/2023 - 01/2011
4Infections
02/2021 - 01/2011
4Adenocarcinoma
06/2020 - 09/2012
4Carcinoma (Carcinomatosis)
01/2017 - 05/2005
4Anorexia
12/2013 - 06/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 01/2020
3Melanoma (Melanoma, Malignant)
08/2023 - 01/2020
3Pneumonia (Pneumonitis)
08/2023 - 01/2011
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023 - 11/2016
3Stomatitis
10/2021 - 01/2011
3Hand-Foot Syndrome
02/2019 - 11/2014
3Anemia
01/2019 - 04/2010
3Lymphatic Metastasis
09/2018 - 09/2000
3Diarrhea
07/2018 - 11/2014
3Hemorrhage
04/2016 - 04/2002
2Ulcerative Colitis
10/2021 - 03/2021
2Enterocolitis
03/2021 - 02/2020
2Febrile Neutropenia
02/2021 - 07/2016
2Ascites
06/2020 - 01/2020
2Hypertension (High Blood Pressure)
01/2019 - 02/2015
2Hypersensitivity (Allergy)
07/2018 - 04/2015
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 11/2016
2Colonic Neoplasms (Colon Cancer)
02/2013 - 05/2011
2Fever (Fevers)
06/2012 - 12/2004
1Hyperammonemia
11/2023
1Brain Diseases (Brain Disorder)
11/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2023
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2023
1Residual Neoplasm
01/2022
1Coinfection
10/2021
1Immediate Hypersensitivity
07/2021

Drug/Important Bio-Agent (IBA)

18Fluorouracil (Carac)FDA LinkGeneric
12/2022 - 09/2000
15NivolumabIBA
10/2023 - 01/2017
15Cisplatin (Platino)FDA LinkGeneric
02/2021 - 09/2000
9Immune Checkpoint InhibitorsIBA
08/2023 - 07/2018
9Irinotecan (Camptosar)FDA LinkGeneric
12/2022 - 04/2008
6Docetaxel (Taxotere)FDA Link
02/2021 - 11/2013
6Bevacizumab (Avastin)FDA Link
05/2018 - 10/2010
6Capecitabine (Xeloda)FDA Link
05/2018 - 10/2010
5Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2022 - 10/2010
5Paclitaxel (Taxol)FDA LinkGeneric
06/2020 - 06/2011
5Trastuzumab (Herceptin)FDA Link
01/2020 - 04/2012
4Leucovorin (Folinic Acid)FDA Link
12/2022 - 04/2008
4AntibodiesIBA
07/2021 - 09/2012
4PlatinumIBA
11/2019 - 06/2011
4GemcitabineFDA Link
10/2018 - 06/2010
3pembrolizumabIBA
08/2023 - 01/2020
3InterferonsIBA
07/2018 - 06/2012
3SteroidsIBA
07/2018 - 01/2011
3Monoclonal AntibodiesIBA
12/2017 - 05/2009
3Sorafenib (BAY 43-9006)FDA Link
02/2015 - 01/2011
2Sunitinib (Sutent)FDA Link
11/2023 - 01/2011
2Tyrosine Kinase InhibitorsIBA
11/2023 - 01/2016
2atezolizumabIBA
08/2023 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2020
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 - 02/2015
2CreatinineIBA
02/2021 - 01/2017
2RamucirumabIBA
06/2020 - 01/2019
2regorafenibIBA
01/2020 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 05/2009
2Immunoglobulin G (IgG)IBA
01/2019 - 12/2017
2Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2013
2EnzymesIBA
07/2018 - 04/2015
2Peptides (Polypeptides)IBA
07/2018 - 04/2015
2Panitumumab (Vectibix)FDA Link
06/2016 - 05/2009
2Methotrexate (Mexate)FDA LinkGeneric
10/2013 - 09/2000
2Cetuximab (Erbitux)FDA Link
02/2013 - 06/2011
2XELOXIBA
04/2011 - 10/2010
2EverolimusFDA Link
01/2011 - 04/2010
2Complementary DNA (cDNA)IBA
06/2007 - 05/2005
1SodiumIBA
01/2022
1Circulating Tumor DNAIBA
01/2022
1Antimicrobial PeptidesIBA
10/2021
1Qingdai compoundIBA
10/2021
1Indigo Carmine (Indigo Blue)IBA
10/2021
1Serum AlbuminIBA
07/2021
1Capsules (Microcapsules)IBA
03/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2021
1tributyl phosphate (TBP)IBA
01/2021
1130-nm albumin-bound paclitaxelIBA
06/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2020

Therapy/Procedure

39Drug Therapy (Chemotherapy)
08/2023 - 09/2000
33Therapeutics
01/2023 - 09/2000
5Chemoradiotherapy
01/2022 - 06/2010
4Salvage Therapy
11/2023 - 06/2016
4Induction Chemotherapy
02/2021 - 11/2016
3Radiotherapy
01/2019 - 04/2016
2Neoadjuvant Therapy
03/2023 - 01/2022
2Lymph Node Excision (Lymph Node Dissection)
01/2019 - 09/2018
2Combination Drug Therapy (Combination Chemotherapy)
12/2013 - 10/2010
2Adjuvant Chemotherapy
05/2011 - 09/2000